Cardinal Health Inc (CAH) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Cardinal Health Inc (CAH)

237.56

+1.34 (0.57%)

as of Jun 30, 2026, 8:00:00 pm Market Open.

44 watching

Investor Insights

Jun 30, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Experts are generally optimistic about Cardinal Health Inc, citing its recent acquisition of a urology company as a positive strategic move, with one expert setting a target of $300. The company is recognized as one of the three major distributors in healthcare, benefiting from the aging population and an increase in prescriptions, which provide favorable market conditions. It trades at a forward P/E of 16x, with projected EPS growth of 13%, indicating a nearly 1x PEG ratio. The stock's recent decline is attributed to the acquisition of Solaris, which some analysts view as a buying opportunity. With a consistent earnings growth profile and a modest yield of 1.35%, the consensus remains cautiously optimistic about its long-term potential.

Consensus

Positive

Valuation

Undervalued

Similar

Mediware, MD

DON'T BUY

Return on equity has been very strong, but the businesses are changing. Prefers others in this sector.

PAST TOP PICK

(Was a top pick Jul 17/03. Down 11%.) The day after it was picked, the Company announced a decrease in their earnings so this pick was an error.

BUY

A pretty good buy right now.

TOP PICK

Competition is limited. Has revenue growth of 20%. Good price.

PAST TOP PICK

(Was a top pick on April 22/03. Down 1%.) Still likes.

TOP PICK

Thin margins, but very large volumes gives good earnings growth, probably in the high teens.

BUY ON WEAKNESS

1 out of 6 drugs sold goes through this company. Buy at $60 or below.

BUY

Should do well, but buy on weakness. At a good price now.

BUY

Benefiting from a trend in drug distribution. Prefers over Walgreen.

DON'T BUY

High quality company. Strong mngmnt. Valuation is too high now.

Showing 31 to 40 of 40 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Bruce Murray

The Murray Wealth Group

Joe Terranova

Virtus Investment Partners

Stephanie Link, Chief investment strategist, Hightower

Hightower

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Cardinal Health Inc (CAH)